San Diego biotech allies warn drug pricing bill stifles cures. Critics don’t buy it

September 17, 2021

San Diego biotech allies warn drug pricing bill stifles cures. Critics don’t buy it A bill that would allow Medicare to negotiate drug prices is fueling a fierce debate over how best to make medications affordable. San Diego’s biotech industry and allies are balking at a bill that would allow Medicare to negotiate drug prices, insisting the proposal would stifle innovation even as proponents accuse the industry of hording profits.

Read the source article at The San Diego Union
2021-09-17 03:08:38

Share This Story!